Literature DB >> 172502

Saccharopine dehydrogenase. Substrate inhibition studies.

M Fujioka.   

Abstract

In the direction of reductive condensation of alpha-ketoglutarate and lysine, saccharopine dehydrogenase (N6-(glutar-2-yl)-L-lysine:NAD oxidoreductase (lysine-forming) is inhibited by high concentrations of alpha-ketoglutarate and lysine, but not by NADH. NAD+ and saccharopine show no substrate inhibition in the reverse direction. Substrate inhibition by alpha-ketoglutarate and lysine is linear uncompetitive versus NADH. However, when the inhibition is examined with alpha-ketoglutarate or lysine as the variable substrate, the double reciprocal plots show a family of curved lines concave up. The curvature is more pronounced with increasing concentrations of the inhibitory substrate, suggesting an interaction of variable substrate with the enzyme form carrying the inhibitory substrate. These inhibition patterns, the lack of interaction of structural analogs of lysine such as ornithine and norleucine with the E-NAD+ complex (Fujioka M., and Nakatani, Y. (1972) Eur. J. Biochem. 25, 301-307), the identity of values of inhibition constants of alpha-ketoglutarate and lysine obtained with either one as the substrate inhibitor, and the substrate inhibition data in the presence of a reaction product, NAD+, are consistent with the mechanism that substrate inhibition results from the formation of a dead-end E-NAD+-alpha-ketoglutarate complex followed by the addition of lysine to this abortive complex.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 172502

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  3 in total

1.  General and specific controls of lysine biosynthesis in Saccharomyces cerevisiae.

Authors:  L A Urrestarazu; C W Borell; J K Bhattacharjee
Journal:  Curr Genet       Date:  1985       Impact factor: 3.886

2.  Molecular and functional analysis of the LYS1 gene of Candida albicans.

Authors:  R Garrad; T M Schmidt; J K Bhattacharjee
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

3.  New Therapeutic Candidates for the Treatment of Malassezia pachydermatis -Associated Infections.

Authors:  Angie Sastoque; Sergio Triana; Kevin Ehemann; Lina Suarez; Silvia Restrepo; Han Wösten; Hans de Cock; Miguel Fernández-Niño; Andrés Fernando González Barrios; Adriana Marcela Celis Ramírez
Journal:  Sci Rep       Date:  2020-03-17       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.